A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.
Indias pharmaceutical companies have a unique opportunity to lead global growth for years to come However there is a significant gap between the strategic vision and operational realities of the sector Firms are facing challenges on multiple fronts in their supply chains They need to overcome these ..
The article talks about the Swiss Generics market the penetration rate of generics in Switzerland why generics are a safe and smarter choice manufactured to modern standards with affordable prices and the threat of government forcing generic companies to benchmark their prices to nine European count..
Clinical development is a complex puzzle with elements such as geography regulatory requirements epidemiology technology and expertise all contributing to successfully bringing a product to market Development of TLC388 in Asia for the treatment of liver cancer illustrates geographic advantages in ac..
The Indian pharmaceuticals market has become the largest exporter of medicines by volume India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume In terms of market size the Indian pharma industry which is expect..
Very similar firms often achieve very different results This is explained by their genetic switches..
The future of pharma regulations is challenging with diverse and complex regulations globally It will be challenging for industry to adapt to regulated and semiregulated markets alike while attempting to develop a harmonised strategy with evergrowing cost pressure on offpatent products for both smal..
All companies plan to succeed but only a few succeed in planning The differences between them lie in how they answer seven fundamental questions..
Biosimilars can exhibit tremendous heterogeneity in terms of structural and posttranslational modifications Therefore comprehensive characterisation of biosimilars is necessary to ensure safety and efficacy The analytical tests to demonstrate similarity of a biosimilar product to a reference drug wi..
If we are to maintain a healthy global market for vaccines RD and production as well as optimising its benefit to mankind those taking public health and financial decisions about vaccinations must have access to the expertise that will prevent them from taking pricing and procurement decisions that ..
In recent years there has been a proliferation of pharmacovigilance guidelines and regulations Regulatory authorities have implemented different requirements templates and regulations and some of them have asked pharmaceutical companies to produce many documents with overlapping content These requir..